Merck said in a brief statement that discussions are "advanced" but noted that "critical conditions have yet to be met" ...
Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback